E Mak1, N Bergsland2, M G Dwyer3, R Zivadinov4, N Kandiah5. 1. From the Department of Neurology (E.M., N.B., M.G.D., R.Z.), Buffalo Neuroimaging Analysis Center Department of Neurology (E.M., N.K.), National Neuroscience Institute, Singapore. 2. From the Department of Neurology (E.M., N.B., M.G.D., R.Z.), Buffalo Neuroimaging Analysis Center Istituto de Ricovero e Cura a Carattere Scientifico "S. Maria Nascente," Don Gnocchi Foundation (N.B.), Milan, Italy. 3. From the Department of Neurology (E.M., N.B., M.G.D., R.Z.), Buffalo Neuroimaging Analysis Center. 4. From the Department of Neurology (E.M., N.B., M.G.D., R.Z.), Buffalo Neuroimaging Analysis Center MR Imaging Clinical Translational Research Center (R.Z.), School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York rzivadinov@bnac.net nagaendran_kandiah@nni.com.sg. 5. Department of Neurology (E.M., N.K.), National Neuroscience Institute, Singapore rzivadinov@bnac.net nagaendran_kandiah@nni.com.sg.
Abstract
BACKGROUND AND PURPOSE: The involvement of subcortical deep gray matter and cortical thinning associated with mild Parkinson disease remains poorly understood. We assessed cortical thickness and subcortical volumes in patients with Parkinson disease without dementia and evaluated their associations with cognitive dysfunction. MATERIALS AND METHODS: The study included 90 patients with mild Parkinson disease without dementia. Neuropsychological assessments classified the sample into patients with mild cognitive impairment (n = 25) and patients without cognitive impairment (n = 65). Volumetric data for subcortical structures were obtained by using the FMRIB Integrated Registration and Segmentation Tool while whole-brain, gray and white matter volumes were estimated by using Structural Image Evaluation, with Normalization of Atrophy. Vertex-based shape analyses were performed to investigate shape differences in subcortical structures. Vertex-wise group differences in cortical thickness were also assessed. Volumetric comparisons between Parkinson disease with mild cognitive impairment and Parkinson disease with no cognitive impairment were performed by using ANCOVA. Associations of subcortical structures with both cognitive function and disease severity were assessed by using linear regression models. RESULTS: Compared with Parkinson disease with no cognitive impairment, Parkinson disease with mild cognitive impairment demonstrated reduced volumes of the thalamus (P = .03) and the nucleus accumbens (P = .04). Significant associations were found for the nucleus accumbens and putamen with performances on the attention/working memory domains (P < .05) and nucleus accumbens and language domains (P = .04). The 2 groups did not differ in measures of subcortical shape or in cortical thickness. CONCLUSIONS: Patients with Parkinson disease with mild cognitive impairment demonstrated reduced subcortical volumes, which were associated with cognitive deficits. The thalamus, nucleus accumbens, and putamen may serve as potential biomarkers for Parkinson disease-mild cognitive impairment.
BACKGROUND AND PURPOSE: The involvement of subcortical deep gray matter and cortical thinning associated with mild Parkinson disease remains poorly understood. We assessed cortical thickness and subcortical volumes in patients with Parkinson disease without dementia and evaluated their associations with cognitive dysfunction. MATERIALS AND METHODS: The study included 90 patients with mild Parkinson disease without dementia. Neuropsychological assessments classified the sample into patients with mild cognitive impairment (n = 25) and patients without cognitive impairment (n = 65). Volumetric data for subcortical structures were obtained by using the FMRIB Integrated Registration and Segmentation Tool while whole-brain, gray and white matter volumes were estimated by using Structural Image Evaluation, with Normalization of Atrophy. Vertex-based shape analyses were performed to investigate shape differences in subcortical structures. Vertex-wise group differences in cortical thickness were also assessed. Volumetric comparisons between Parkinson disease with mild cognitive impairment and Parkinson disease with no cognitive impairment were performed by using ANCOVA. Associations of subcortical structures with both cognitive function and disease severity were assessed by using linear regression models. RESULTS: Compared with Parkinson disease with no cognitive impairment, Parkinson disease with mild cognitive impairment demonstrated reduced volumes of the thalamus (P = .03) and the nucleus accumbens (P = .04). Significant associations were found for the nucleus accumbens and putamen with performances on the attention/working memory domains (P < .05) and nucleus accumbens and language domains (P = .04). The 2 groups did not differ in measures of subcortical shape or in cortical thickness. CONCLUSIONS:Patients with Parkinson disease with mild cognitive impairment demonstrated reduced subcortical volumes, which were associated with cognitive deficits. The thalamus, nucleus accumbens, and putamen may serve as potential biomarkers for Parkinson disease-mild cognitive impairment.
Authors: Y Nishio; K Hirayama; A Takeda; Y Hosokai; T Ishioka; K Suzuki; Y Itoyama; S Takahashi; E Mori Journal: Eur J Neurol Date: 2010-03-09 Impact factor: 6.089
Authors: Turi O Dalaker; Robert Zivadinov; Jan P Larsen; Mona K Beyer; Jennifer L Cox; Guido Alves; Kolbjorn Bronnick; Ole-Bjorn Tysnes; Ronald Antulov; Michael G Dwyer; Dag Aarsland Journal: Mov Disord Date: 2010-04-15 Impact factor: 10.338
Authors: Robert Zivadinov; Mari Heininen-Brown; Claudiu V Schirda; Guy U Poloni; Niels Bergsland; Christopher R Magnano; Jacqueline Durfee; Cheryl Kennedy; Ellen Carl; Jesper Hagemeier; Ralph H B Benedict; Bianca Weinstock-Guttman; Michael G Dwyer Journal: Neuroimage Date: 2011-07-27 Impact factor: 6.556
Authors: C Tessa; M Giannelli; R Della Nave; C Lucetti; C Berti; A Ginestroni; U Bonuccelli; M Mascalchi Journal: AJNR Am J Neuroradiol Date: 2008-01-09 Impact factor: 3.825
Authors: Nagaendran Kandiah; Kaavya Narasimhalu; Puay-Ngoh Lau; Soo-Hoon Seah; Wing Lok Au; Louis C S Tan Journal: Mov Disord Date: 2009-03-15 Impact factor: 10.338
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: S Gazzina; E Premi; R Turrone; J Acosta-Cabronero; M C Rizzetti; M S Cotelli; R Gasparotti; A Padovani; B Borroni Journal: J Neurol Date: 2016-05-26 Impact factor: 4.849
Authors: A Meijerman; H Amiri; M D Steenwijk; M A Jonker; R A van Schijndel; K S Cover; H Vrenken Journal: AJNR Am J Neuroradiol Date: 2017-11-30 Impact factor: 3.825
Authors: Santosh K Yadav; Nagarajan Kathiresan; Suyash Mohan; Georgia Vasileiou; Anup Singh; Deepak Kaura; Elias R Melhem; Rakesh K Gupta; Ena Wang; Francesco M Marincola; Arijitt Borthakur; Mohammad Haris Journal: J Neurol Date: 2016-08-20 Impact factor: 4.849
Authors: Elizabeth R Wallace; Suzanne C Segerstrom; Craig G van Horne; Frederick A Schmitt; Lisa M Koehl Journal: Neuropsychol Rev Date: 2021-04-16 Impact factor: 7.444